PubMed · 1994 · 17 citations · 24 references
Open access
MedicineEndocrinologyImmunologyAutoimmunityDiabetologyImmunopathologyAutoimmune Disease PathogenesisAutoimmune Disease PathologyAutoimmune DiseasesDiabetes MellitusImmunosuppressionRegulation Of AutoimmunityAutoimmune Disease ImmunosuppressionCell Proliferation IndicesDiabetes Mellitus PathophysiologyImmunosuppressive CompoundsImmunosuppressive FunctionInterferon Gamma ProductionInterferon Gamma ResponseInterferon-gamma Responses
Diabetes-prone (DP) BB rats spontaneously develop a hyperglycaemic condition which closely resembles human insulin-dependent diabetes mellitus (IDDM), both in terms of clinical and histological features. The incidence of IDDM was significantly reduced when these animals were treated with 2 or 4 mg fusidic acid (FA)/day i.m. from day 30 to day 120 of age. In addition, the mean insulitis score was significantly diminished in the animals treated with FA compared to both vehicle-treated and untreated controls. Finally, 2 mg/day of FA i.m. prevented cell proliferation and interferon-gamma secretion from peripheral blood mononuclear cells upon ex vivo stimulation with concanavalin A. The capacity of FA to substantially reduce the incidence of autoimmune diabetes in a well-known animal model of human IDDM supports previous observations regarding the immunosuppressive properties of FA and its potential use in the treatment of human autoimmune diabetes.
24
Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset
C. R. Stiller, John Dupré, Michael Gent et al. · Science · 1984 · 558 citations
G Feutren, R Assan, Gérard Karsenty et al. · The Lancet · 1986 · 449 citations